Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Sep 1;156(3):912-7.
doi: 10.1084/jem.156.3.912.

Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors

Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors

M G Goodman et al. J Exp Med. .

Abstract

The mechanism by which human C5a anaphylatoxin augments the primary humoral response of murine splenocytes to antigen has been investigated. Culture supernatants were generated from splenic adherent cells or macrophage cell lines after exposure to a brief pulse of human C5a. Supernatants from the macrophage-like cell line P388D1, which bears surface receptors for C5a, enhance the PFC response to antigen, whereas those from the closely related cell line P388, which lacks surface receptors for C5a, fail to cause enhancement. Supernatants from splenic adherent cells, which also bear C5a receptors, similarly augment the SRBC response. Active supernatants, but not those devoid of activity, were shown to contain interleukin 1 (IL-1) activity by both the thymocyte mitogenesis and thymocyte costimulator assays. None of the supernatants contained IL-2 activity. These observations suggest that the recently described role of human C5a as an immunopotentiating modulator is mediated by its ability to induce production of IL-1 upon binding to specific receptors at the macrophage cell surface.

PubMed Disclaimer

References

    1. J Exp Med. 1967 Sep 1;126(3):423-42 - PubMed
    1. Proc R Soc Lond B Biol Sci. 1974 Aug 27;187(1086):65-81 - PubMed
    1. J Exp Med. 1975 Sep 1;142(3):600-10 - PubMed
    1. Cell Immunol. 1976 Jan;21(1):133-45 - PubMed
    1. J Immunol. 1977 Jan;118(1):77-82 - PubMed

Publication types